semaglutide losing muscle Does Cause Loss? The GLP-1 Revolution Comes With

Compounded versions are prepared by a pharmacy, cost a fraction of that, and are not FDA-approved finished products

Watch the inspiring before and after journey

It was observed that the glycated hemoglobin was significantly reduced in patients who were treated with Tirzepatide compared to Semaglutide in a dose-dependent manner: The HbA1C reduced at week 40 from the baseline by 2.01%, 2.24%, and 2.30% with Tirzepatide 5 mg, 10 mg, and 15 mg compared to Semaglutide 1 mg weekly (1.86%) A greater percentage of the patients in the Tirzepatide groups achieved the target HbA1C at week 40 compared to Semaglutide

Rahuman AA, Venkatesan P